ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Migraine Treatment Medication Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0H15275
Home | Market Reports | Health| Health Conditions| Pain Management
Global Migraine Treatment Medication Market Research Report 2023
BUY CHAPTERS

Global Migraine Treatment Medication Market Research Report 2025

Code: QYRE-Auto-0H15275
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Pfizer Inc
Novartis
TEVA
Sun Pharma
Grünenthal
Endo Pharmaceuticals
Merck
Johnson & Johnson
AbbVie
Abbott
Bayer
Eli Lilly
Kowa Pharmaceuticals America
Astrazeneca plc

Migraine Treatment Medication Market

The global market for Migraine Treatment Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Migraine is a neurological condition that typically causes painful headache attacks that occur with additional symptoms, such as sensitivity to light, sound, smell, or touch. Migraine treatment medications aim to alleviate or prevent migraine headaches.
North American market for Migraine Treatment Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Migraine Treatment Medication is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Migraine Treatment Medication in Acute Migraine is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Migraine Treatment Medication include GSK, Pfizer, Novartis, Teva, Sun Pharma, Grünenthal, Endo Pharmaceuticals, Merck, Johnson & Johnson, AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Migraine Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Treatment Medication.
The Migraine Treatment Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Migraine Treatment Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Migraine Treatment Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Migraine Treatment Medication Market Report

Report Metric Details
Report Name Migraine Treatment Medication Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Pfizer, Novartis, Teva, Sun Pharma, Grünenthal, Endo Pharmaceuticals, Merck, Johnson & Johnson, AbbVie, Abbott, Bayer, Eli Lilly, Kowa Pharmaceuticals America, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Migraine Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Migraine Treatment Medication Market report?

Ans: The main players in the Migraine Treatment Medication Market are GSK, Pfizer, Novartis, Teva, Sun Pharma, Grünenthal, Endo Pharmaceuticals, Merck, Johnson & Johnson, AbbVie, Abbott, Bayer, Eli Lilly, Kowa Pharmaceuticals America, AstraZeneca

What are the Application segmentation covered in the Migraine Treatment Medication Market report?

Ans: The Applications covered in the Migraine Treatment Medication Market report are Acute Migraine, Chronic Migraine

What are the Type segmentation covered in the Migraine Treatment Medication Market report?

Ans: The Types covered in the Migraine Treatment Medication Market report are Triptans, NSAIDs, Others

Recommended Reports

Migraine & Pain Relief

Neurological Diseases

Pain Management

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Treatment Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Migraine Treatment Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Migraine
1.3.3 Chronic Migraine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Migraine Treatment Medication Market Perspective (2020-2031)
2.2 Global Migraine Treatment Medication Growth Trends by Region
2.2.1 Global Migraine Treatment Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Migraine Treatment Medication Historic Market Size by Region (2020-2025)
2.2.3 Migraine Treatment Medication Forecasted Market Size by Region (2026-2031)
2.3 Migraine Treatment Medication Market Dynamics
2.3.1 Migraine Treatment Medication Industry Trends
2.3.2 Migraine Treatment Medication Market Drivers
2.3.3 Migraine Treatment Medication Market Challenges
2.3.4 Migraine Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Treatment Medication Players by Revenue
3.1.1 Global Top Migraine Treatment Medication Players by Revenue (2020-2025)
3.1.2 Global Migraine Treatment Medication Revenue Market Share by Players (2020-2025)
3.2 Global Migraine Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Migraine Treatment Medication Revenue
3.4 Global Migraine Treatment Medication Market Concentration Ratio
3.4.1 Global Migraine Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Treatment Medication Revenue in 2024
3.5 Global Key Players of Migraine Treatment Medication Head office and Area Served
3.6 Global Key Players of Migraine Treatment Medication, Product and Application
3.7 Global Key Players of Migraine Treatment Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Treatment Medication Breakdown Data by Type
4.1 Global Migraine Treatment Medication Historic Market Size by Type (2020-2025)
4.2 Global Migraine Treatment Medication Forecasted Market Size by Type (2026-2031)
5 Migraine Treatment Medication Breakdown Data by Application
5.1 Global Migraine Treatment Medication Historic Market Size by Application (2020-2025)
5.2 Global Migraine Treatment Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Migraine Treatment Medication Market Size (2020-2031)
6.2 North America Migraine Treatment Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Migraine Treatment Medication Market Size by Country (2020-2025)
6.4 North America Migraine Treatment Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Migraine Treatment Medication Market Size (2020-2031)
7.2 Europe Migraine Treatment Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Migraine Treatment Medication Market Size by Country (2020-2025)
7.4 Europe Migraine Treatment Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Migraine Treatment Medication Market Size (2020-2031)
8.2 Asia-Pacific Migraine Treatment Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Migraine Treatment Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific Migraine Treatment Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Migraine Treatment Medication Market Size (2020-2031)
9.2 Latin America Migraine Treatment Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Migraine Treatment Medication Market Size by Country (2020-2025)
9.4 Latin America Migraine Treatment Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Treatment Medication Market Size (2020-2031)
10.2 Middle East & Africa Migraine Treatment Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Migraine Treatment Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa Migraine Treatment Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Migraine Treatment Medication Introduction
11.1.4 GSK Revenue in Migraine Treatment Medication Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Migraine Treatment Medication Introduction
11.2.4 Pfizer Revenue in Migraine Treatment Medication Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Migraine Treatment Medication Introduction
11.3.4 Novartis Revenue in Migraine Treatment Medication Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Migraine Treatment Medication Introduction
11.4.4 Teva Revenue in Migraine Treatment Medication Business (2020-2025)
11.4.5 Teva Recent Development
11.5 Sun Pharma
11.5.1 Sun Pharma Company Details
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Migraine Treatment Medication Introduction
11.5.4 Sun Pharma Revenue in Migraine Treatment Medication Business (2020-2025)
11.5.5 Sun Pharma Recent Development
11.6 Grünenthal
11.6.1 Grünenthal Company Details
11.6.2 Grünenthal Business Overview
11.6.3 Grünenthal Migraine Treatment Medication Introduction
11.6.4 Grünenthal Revenue in Migraine Treatment Medication Business (2020-2025)
11.6.5 Grünenthal Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Details
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Migraine Treatment Medication Introduction
11.7.4 Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2020-2025)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Migraine Treatment Medication Introduction
11.8.4 Merck Revenue in Migraine Treatment Medication Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Treatment Medication Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Treatment Medication Business (2020-2025)
11.9.5 Johnson & Johnson Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Migraine Treatment Medication Introduction
11.10.4 AbbVie Revenue in Migraine Treatment Medication Business (2020-2025)
11.10.5 AbbVie Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Migraine Treatment Medication Introduction
11.11.4 Abbott Revenue in Migraine Treatment Medication Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Migraine Treatment Medication Introduction
11.12.4 Bayer Revenue in Migraine Treatment Medication Business (2020-2025)
11.12.5 Bayer Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Migraine Treatment Medication Introduction
11.13.4 Eli Lilly Revenue in Migraine Treatment Medication Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Company Details
11.14.2 Kowa Pharmaceuticals America Business Overview
11.14.3 Kowa Pharmaceuticals America Migraine Treatment Medication Introduction
11.14.4 Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2020-2025)
11.14.5 Kowa Pharmaceuticals America Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Details
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Migraine Treatment Medication Introduction
11.15.4 AstraZeneca Revenue in Migraine Treatment Medication Business (2020-2025)
11.15.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GSK
Pfizer Inc
Novartis
TEVA
Sun Pharma
Grünenthal
Endo Pharmaceuticals
Merck
Johnson & Johnson
AbbVie
Abbott
Bayer
Eli Lilly
Kowa Pharmaceuticals America
Astrazeneca plc
List of Tables
 Table 1. Global Migraine Treatment Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Triptans
 Table 3. Key Players of NSAIDs
 Table 4. Key Players of Others
 Table 5. Global Migraine Treatment Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Migraine Treatment Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Migraine Treatment Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Migraine Treatment Medication Market Share by Region (2020-2025)
 Table 9. Global Migraine Treatment Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Migraine Treatment Medication Market Share by Region (2026-2031)
 Table 11. Migraine Treatment Medication Market Trends
 Table 12. Migraine Treatment Medication Market Drivers
 Table 13. Migraine Treatment Medication Market Challenges
 Table 14. Migraine Treatment Medication Market Restraints
 Table 15. Global Migraine Treatment Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Migraine Treatment Medication Market Share by Players (2020-2025)
 Table 17. Global Top Migraine Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2024)
 Table 18. Ranking of Global Top Migraine Treatment Medication Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Migraine Treatment Medication Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Migraine Treatment Medication, Headquarters and Area Served
 Table 21. Global Key Players of Migraine Treatment Medication, Product and Application
 Table 22. Global Key Players of Migraine Treatment Medication, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Migraine Treatment Medication Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Migraine Treatment Medication Revenue Market Share by Type (2020-2025)
 Table 26. Global Migraine Treatment Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Migraine Treatment Medication Revenue Market Share by Type (2026-2031)
 Table 28. Global Migraine Treatment Medication Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Migraine Treatment Medication Revenue Market Share by Application (2020-2025)
 Table 30. Global Migraine Treatment Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Migraine Treatment Medication Revenue Market Share by Application (2026-2031)
 Table 32. North America Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Migraine Treatment Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Migraine Treatment Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Migraine Treatment Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Migraine Treatment Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Migraine Treatment Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Migraine Treatment Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Migraine Treatment Medication Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Migraine Treatment Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Migraine Treatment Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Migraine Treatment Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Migraine Treatment Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 47. GSK Company Details
 Table 48. GSK Business Overview
 Table 49. GSK Migraine Treatment Medication Product
 Table 50. GSK Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 51. GSK Recent Development
 Table 52. Pfizer Company Details
 Table 53. Pfizer Business Overview
 Table 54. Pfizer Migraine Treatment Medication Product
 Table 55. Pfizer Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 56. Pfizer Recent Development
 Table 57. Novartis Company Details
 Table 58. Novartis Business Overview
 Table 59. Novartis Migraine Treatment Medication Product
 Table 60. Novartis Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 61. Novartis Recent Development
 Table 62. Teva Company Details
 Table 63. Teva Business Overview
 Table 64. Teva Migraine Treatment Medication Product
 Table 65. Teva Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 66. Teva Recent Development
 Table 67. Sun Pharma Company Details
 Table 68. Sun Pharma Business Overview
 Table 69. Sun Pharma Migraine Treatment Medication Product
 Table 70. Sun Pharma Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 71. Sun Pharma Recent Development
 Table 72. Grünenthal Company Details
 Table 73. Grünenthal Business Overview
 Table 74. Grünenthal Migraine Treatment Medication Product
 Table 75. Grünenthal Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 76. Grünenthal Recent Development
 Table 77. Endo Pharmaceuticals Company Details
 Table 78. Endo Pharmaceuticals Business Overview
 Table 79. Endo Pharmaceuticals Migraine Treatment Medication Product
 Table 80. Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 81. Endo Pharmaceuticals Recent Development
 Table 82. Merck Company Details
 Table 83. Merck Business Overview
 Table 84. Merck Migraine Treatment Medication Product
 Table 85. Merck Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 86. Merck Recent Development
 Table 87. Johnson & Johnson Company Details
 Table 88. Johnson & Johnson Business Overview
 Table 89. Johnson & Johnson Migraine Treatment Medication Product
 Table 90. Johnson & Johnson Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 91. Johnson & Johnson Recent Development
 Table 92. AbbVie Company Details
 Table 93. AbbVie Business Overview
 Table 94. AbbVie Migraine Treatment Medication Product
 Table 95. AbbVie Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 96. AbbVie Recent Development
 Table 97. Abbott Company Details
 Table 98. Abbott Business Overview
 Table 99. Abbott Migraine Treatment Medication Product
 Table 100. Abbott Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 101. Abbott Recent Development
 Table 102. Bayer Company Details
 Table 103. Bayer Business Overview
 Table 104. Bayer Migraine Treatment Medication Product
 Table 105. Bayer Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 106. Bayer Recent Development
 Table 107. Eli Lilly Company Details
 Table 108. Eli Lilly Business Overview
 Table 109. Eli Lilly Migraine Treatment Medication Product
 Table 110. Eli Lilly Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 111. Eli Lilly Recent Development
 Table 112. Kowa Pharmaceuticals America Company Details
 Table 113. Kowa Pharmaceuticals America Business Overview
 Table 114. Kowa Pharmaceuticals America Migraine Treatment Medication Product
 Table 115. Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 116. Kowa Pharmaceuticals America Recent Development
 Table 117. AstraZeneca Company Details
 Table 118. AstraZeneca Business Overview
 Table 119. AstraZeneca Migraine Treatment Medication Product
 Table 120. AstraZeneca Revenue in Migraine Treatment Medication Business (2020-2025) & (US$ Million)
 Table 121. AstraZeneca Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Migraine Treatment Medication Picture
 Figure 2. Global Migraine Treatment Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Migraine Treatment Medication Market Share by Type: 2024 VS 2031
 Figure 4. Triptans Features
 Figure 5. NSAIDs Features
 Figure 6. Others Features
 Figure 7. Global Migraine Treatment Medication Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Migraine Treatment Medication Market Share by Application: 2024 VS 2031
 Figure 9. Acute Migraine Case Studies
 Figure 10. Chronic Migraine Case Studies
 Figure 11. Migraine Treatment Medication Report Years Considered
 Figure 12. Global Migraine Treatment Medication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Migraine Treatment Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Migraine Treatment Medication Market Share by Region: 2024 VS 2031
 Figure 15. Global Migraine Treatment Medication Market Share by Players in 2024
 Figure 16. Global Top Migraine Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Migraine Treatment Medication Revenue in 2024
 Figure 18. North America Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Migraine Treatment Medication Market Share by Country (2020-2031)
 Figure 20. United States Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Migraine Treatment Medication Market Share by Country (2020-2031)
 Figure 24. Germany Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Migraine Treatment Medication Market Share by Region (2020-2031)
 Figure 32. China Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Migraine Treatment Medication Market Share by Country (2020-2031)
 Figure 40. Mexico Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Migraine Treatment Medication Market Share by Country (2020-2031)
 Figure 44. Turkey Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Migraine Treatment Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. GSK Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 48. Pfizer Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 49. Novartis Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 50. Teva Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 51. Sun Pharma Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 52. Grünenthal Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 53. Endo Pharmaceuticals Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 55. Johnson & Johnson Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 56. AbbVie Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 57. Abbott Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 58. Bayer Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 59. Eli Lilly Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 60. Kowa Pharmaceuticals America Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 61. AstraZeneca Revenue Growth Rate in Migraine Treatment Medication Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Prescription Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Migraine Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Migraine Treatments Market Research Report 2024
Prescription Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Migraine Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Migraine Treatment Market Research Report 2024
Global Preventive Treatment of Migraines Market Research Report 2024
Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Migraine Headache Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trigeminal Neuralgia Treatment Market Insights Forecast to 2030
Global Headache Relief Wearable Device Market Research Report 2024
Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Migraine Drugs Market Research Report 2025
Global Trigeminal Neuralgia Treatment Medicine Market Insights Forecast to 2030
OTC Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions